Photo by Serena Taylor/Newcastle United via Getty Images

According to 90min, Newcastle have drafted two separate transfer shortlists as the new owners look to strengthen the Magpies in 2022.

What’s the story?

Well, the Public Investment Fund of Saudi Arabia (PIF), Amanda Staveley, Mehrdad Ghodoussi and Jamie Reuben are clearly intent on doing things properly.

Your Club’s Player Who Newcastle ‘WILL SIGN’

BridTV
5700
Your Club’s Player Who Newcastle ‘WILL SIGN’
880085
880085
center
13872

Instead of going transfer crazy, submitting £100m bids here and there, it seems a measured approach is being taken.

After Mike Ashley was ousted, the news owners have drafted a shortlist for the coming January window, as well as one for the summer.

Newcastle realise the top players will not want to join a struggling side mid-season, especially one not involved in European football.

As a result, PIF have identified a list of realistic, mid-season targets, with seven names mentioned by 90min.

Which transfers are Newcastle eyeing?

Photo by Michael Driver/MI News/NurPhoto via Getty Images

Manchester United trio Jesse Lingard, Nemanja Matic and Phil Jones are named, as well as Chelsea duo Ross Barkley and Ruben Loftus-Cheek.

Rangers forward Alfredo Morelos and Burnley centre-back James Tarkowski are the other two targets.

In Tarkowski’s case, 90min state that Newcastle believe they can get that deal done very quickly, as his contract expires in June.

As for the more ambitious summer shortlist, no names are mentioned.

Photo by Michael Driver/MI News/NurPhoto via Getty Images

However, the likes of Dele Alli, Philippe Coutinho and even Harry Kane have been mentioned as targets in the last week by other outlets.

In our view, you can expect PIF to pursue that calibre of player when the summer of 2022 arrives – it’s like a real life FIFA Career Mode.

By the start of the 2022/23 campaign, Newcastle could look utterly unrecognisable – we can’t wait to see who PIF lure to Tyneside.

In other news, £30m Arsenal man sends message to David Brooks after Hodgkin's Lymphoma diagnosis